Active, Not Recruiting
Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.
NCT03773367
- Conditions
- Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Oslo University Hospital, Ullevål Hospital Oslo, Norway
- Lund University Hospital Lund, Sweden
- Karolinska University Hospital Stockholm, Sweden
- Centrallasarettet i Växjö Vaxjo, Sweden